Palantir Q2 Was a Blowout. The Multiple Says It Still Isn't Cheap.

Palantir delivered another quarter where the revenue growth rate made headlines and the stock moved 10% higher in after-hours trading. Revenue came in at $1.94 billion, up 93% year-over-year. Adjusted EPS was $0.41 versus an estimate of $0.35. U.S. commercial revenue grew 149%. Management raised full-year guidance to $8.15 billion to $8.16 billion, up from $7.65 billion to $7.66 billion. The stock, which had been down 31% this year and has crashed more than 40% from its all-time highs, got its mojo back.

The headline story is the AI demand surge. The real story is what the multiple says about how much future growth you still need to justify the price.

The earnings beat was real. The margin expansion was real. The guidance raise was real. What's less clear is whether the stock is setting up a buy or just a re-rating of an already expensive business.

1. Growth is accelerating, not decelerating. This is the variable that actually matters. U.S. commercial revenue grew 149% year-over-year to $764 million. U.S. government revenue grew 90% to $809 million. The company closed 220 deals worth over $1 million during the quarter, 98 over $5 million, and 73 over $10 million - up across the board from Q1's already-strong print. The Rule of 40 (a metric combining revenue growth rate and profit margin to assess growth-versus-profitability efficiency) hit 155%. CEO Alex Karp said free cash flow this quarter was larger than total revenue a year ago. That's not hyperbole: $1.22 billion in adjusted free cash flow versus $1.00 billion in Q2 2025 revenue. The business is growing into profitability, not out of it.

2. The multiple has come down from its peak - but "cheaper" isn't cheap. Palantir's trailing P/E was 454x as of mid-2025 and peaked near 688x. It's now around 132x on a trailing basis. That's a massive compression. But forward on a consensus EPS of $0.85 for FY2026, the stock trades near 148x. On FY2027 consensus of roughly $1.38, that's around 91x. Against a $8.15 billion raised full-year revenue guidance, the $301 billion market cap implies roughly 37x this year's sales. Those numbers are down from the 54x sales the market was paying at the start of 2026, but they're not in GARP territory. Even aggressive software platforms don't earn 90x forward earnings unless growth sustains at these levels for years without a stumble.

3. The Q1 beat-and-sell-off told us something about the ceiling. When Palantir reported Q1 results on May 4th - revenue up 85%, EPS of $0.33 beating $0.28 estimates, guidance raised across the board - the stock fell 7%. One of the reasons cited was competitive pressure from AI-native developers like OpenAI and Anthropic eating at Palantir's future value proposition. The market told us, in plain language, that at these levels, even a strong beat doesn't guarantee upside if the narrative shifts. That was the signal the valuation had become the binding constraint.

4. The Q2 jump to the upside proves the same thing, in reverse. With this quarter, the narrative flipped back - "mojo back," "crushed it," the usual chorus - and the stock moved roughly 10% higher. The same mechanism: the multiple is elastic enough to swing both ways on sentiment. The difference is that a 10% re-rating on a 93% growth beat still leaves the stock at the same forward multiple territory. The earnings improved; the price-to-earnings didn't.

5. The break condition is what happens next. The market has already raised its full-year EPS estimate from roughly $0.85 toward $1.17 on updated consensus, and 2027 estimates sit around $1.66 per share, implying 41.88% earnings growth next year. Those are the numbers that would bring the forward P/E toward a more defensible range. The risk is the opposite: any quarter where U.S. commercial growth decelerates from 149% into the 60s or 70s, where deal sizes shrink, or where government contract renewals face political friction, and the multiple compresses again. At 148x forward earnings, there's almost no margin for error.

Where this sets up. Palantir is not a misunderstood stock right now. The growth is genuine, the margins are expanding, and the cash generation is real. The problem isn't that Wall Street is focused on the wrong variable. The problem is that the right variable - growth rate versus forward multiple - still doesn't add up to a bargain. At roughly 148x FY2026 earnings and 37x raised full-year sales, the stock prices in a flawless execution path. That's a fair price for perfection. It's not a deep discount that creates asymmetric upside.

The catalyst for a genuine entry point would be one of two things: a pullback driven by narrative noise that the fundamentals don't support (a repeat of Q1's beat-and-fall), or enough time for earnings growth to catch up and compress the multiple organically. The first is timing-dependent and carries its own risk. The second requires at least two more quarters of 80%+ growth with margin expansion - plausible given the current trajectory, but not guaranteed.

Palantir's business is stronger than most software companies trading at 30x earnings. But at 148x, it's not yet a GARP setup. The stock needs to either earn the multiple with another two quarters of blowout results or find a level where the disconnect between price and forward math actually favors the buyer.